13F HOLDINGS REPORT
Northpond Ventures, LLC
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001104659-24-118975
Total Value
$43.7M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | KYVERNA THERAPEUTICS INC | KYTX | 3,255,426 | $15.9M | 36.46% |
| 2 | VIGIL NEUROSCIENCE INC | 92673K108 | 4,214,498 | $14.3M | 32.82% |
| 3 | CANDEL THERAPEUTICS INC | CADL | 1,935,215 | $13.4M | 30.72% |